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Clinically useful diagnostic tests of dengue virus infection are lacking. We prospectively
evaluated the performance of real-time reverse transcriptase (rRT)-PCR, NS-1 antigen and
IgM antibody tests to conﬁrm dengue virus infection in acute blood specimens from 162
patients presenting with undifferentiated febrile illness compatible with dengue infection.
rRT-PCR was the most sensitive test (89%) and potentially could be used as a single test for
conﬁrmation of dengue infection. NS-1 antigen and IgM antibody were not sufﬁciently sen-
sitive to be used as a single conﬁrmatory test with sensitivities of 54% and 17% respectively.
The speciﬁcities of rRT-PCR, NS-1 antigen and IgM antibody tests were 96%, 100% and 88%CR
erology
valuation
iagnosis
respectively. Combining NS-1 and rRT-PCR or the combination of all three tests resulted in
the highest sensitivity (93%) but speciﬁcities dropped to 96% and 83% respectively. We con-
clude that at least the combination of two tests, either agent detection (rRT-PCR) or antigen
detection (NS-1) plus IgM antibody detection should be used for laboratory conﬁrmation
.
yal Sochailand of dengue infection
© 2010 Ro
. Introduction
Dengue virus is the most important arboviral disease
n humans, with an estimated 100 million cases of dengue
ever (DF) and several hundred thousand cases of dengue
aemorrhagic fever (DHF) each year.1 Cases of DF and
HF were increasingly reported in nine countries within
he South East Asia region between 1985 and 2006, with
hailand reporting the highest number of cases in the
egion until 2003.2 In South East Asia, adults with dengue
irus infection usually present with an acute, undifferenti-
∗ Corresponding author. Tel.: +66 55 545 021; fax: +66 55 545 020.
E-mail address: wanitda@tropmedres.ac (W. Watthanaworawit).
035-9203/$ – see front matter © 2010 Royal Society of Tropical Medicine and H
oi:10.1016/j.trstmh.2010.09.007iety of Tropical Medicine and Hygiene. Published by Elsevier Ltd.
 All rights reserved.
ated, febrile illness.3–7 Previous reports have documented
the difﬁculty in clinically differentiating dengue from
other causes of fever, including leptospirosis8 and scrub
typhus.5 Given this difﬁculty, and the fact that delayed
antimicrobial treatment for such infections may result in
increased mortality, reliable and rapid dengue conﬁrma-
tory tests are needed. Additionally, rapid conﬁrmation of
dengue infection would facilitate improved monitoring of
conﬁrmed cases for development of complications such as
shock or haemorrhage.9Accurate laboratory conﬁrmation of dengue infection
involves a combination of tests depending on timing of
infection. During the acute phase of infection, virus culture,
nucleic acid detection (RT-PCR)10–12 or antigen detection
(for example, by NS-1 antigen ELISA13–15) may be used
ygiene. Published by Elsevier Ltd. All rights reserved.
l SocietyW. Watthanaworawit et al. / Transactions of the Roya
for diagnosis. Serology is also used to conﬁrm infec-
tion and distinguish primary and secondary infections by
determining the differences between IgM and IgG anti-
body response and is currently more widely used as one
of the laboratory diagnostic methods.16 There are a vari-
ety of serological methods described, including ELISA and
haemagglutination inhibition (HI) tests, some of which are
commercially available.17,18 However, serological diagno-
sis of dengue infection requires paired serum specimens,
resulting in retrospective, rather than rapid and clinically
useful, conﬁrmation of infection.
In the present paper, we have prospectively evalu-
ated three diagnostic methodologies (IgM antibody ELISA,
NS-1 antigen ELISA, and real-time reverse transcriptase
[rRT]-PCR) for the detection of dengue virus infection in
patients presentingwith undifferentiated fever in a dengue
endemic area, with the aim of determining the optimal
acute specimen testing strategy in a routine clinical setting.
This is theﬁrst head-to-headassessmentof PCRanda selec-
tion ofwidely-applied commercial serological assays (NS-1
antigen, IgM and IgG antibodies). It is also the ﬁrst diag-
nostic assessment that has demonstrated the improved
diagnostic accuracy when selections of PCR, NS-1 antigen,
IgM and IgG antibody test results are combined.
2. Materials and Methods
2.1. Patients
Shoklo Malaria Research Unit (SMRU) undertakes
surveillance for malaria and other infectious diseases,
and provides general medical care for the migrant and
refugee population, in ﬁve clinics in rural Thailand, on the
Thailand-Myanmar (Burma) border.We conducted dengue
surveillance from April to August 2008 in the SMRU clin-
ics at Mawker Thai village (MKT) and Maela refugee camp
(MLA), both located in rural Tak province approximately
500km northwest of Bangkok. Adult patients (age ≥15
years old) presenting to the clinics with fever ≥38◦C of
less than seven days duration and any clinical symptoms
or physical signs consistent with dengue (abnormal bleed-
ing, eye redness, headache, myalgia or rash) were included
in the surveillance and blood was drawn to inform clini-
cal management (blood culture, complete blood count, and
plasma for serology). Patients who had a clear alternative
diagnosis such as malaria, urinary tract infection or pneu-
monia were excluded from the surveillance.
In addition to dengue virus, patients were serologically
investigated for leptospirosis (ELISA with conﬁrmation by
themicroscopic agglutination test) and rickettsial infection
(ELISA with conﬁrmation by indirect immunoﬂuorescence
assay), the other common causes of undifferentiated fever
in SE Asia.
2.2. Plasma specimensA 6ml acute venous blood specimen was collected
from each patient in a sterile EDTA tube (Becton Dick-
inson, Franklin Lakes, NJ, USA) for dengue rRT-PCR, NS-1
antigen detection, and dengue IgMand IgG antibody detec-
tion tests. The patients were reviewed at a 10–14 dayof Tropical Medicine and Hygiene 105 (2011) 32–37 33
follow-upvisit anda repeat6mlconvalescentvenousblood
specimen was collected for dengue IgM and IgG antibody
tests. Plasma was separated by centrifugation and frozen
at −80 ◦C prior to the assays.
2.3. RNA extraction and RT-PCR
Viral RNAwas extracted from150l of the acuteplasma
specimens using the NucleoSpin RNA virus extraction kit
(Macherey Nagel, Düren, Germany) according to the man-
ufacturer’s instructions and was stored at −80 ◦C prior
to testing. One-step SYBR Green-based rRT-PCR, modiﬁed
from Shu et al., was performed using the RotorGene 6000
real-time PCR system (Corbett Research, San Francisco, CA,
USA).11 The reaction volumewas 25l, comprising 10l of
extracted RNA, 1l of each primer (10M), 12.5l of 2X
SYBR Green reaction mix (containing 0.4mM of each dNTP
and 6mM MgSO4) and 0.5l of SuperScript III RT/Platinum
Taq Mix (SuperScript III Platinum SYBR Green One-Step
QuantitativeRT-PCRKit, Invitrogen, Carlsbad, CA,USA). The
ampliﬁcation conditions consisted of reverse transcription
at 50 ◦C for30min, 95 ◦C for5min for Taq inhibitor inactiva-
tion, followedby45cyclesof 95 ◦C for10 s, 54 ◦C for30 sand
72 ◦C for 30 s. Melting curve analysis was used to conﬁrm
the speciﬁcity of the amplicons. Positive (extracted RNA
from control strains of DENV1-4) and negative controls
were included in each PCR run and the run only accepted
if all controls gave appropriate results.
The serotype of dengue virus was sought from the acute
plasma specimen in all patients with serologically con-
ﬁrmed dengue infection using a nested RT-PCR assay,12
modiﬁedby theArmedForcesResearch Institute ofMedical
Sciences (AFRIMS), Bangkok, Thailand.19
2.4. NS-1 antigen detection
The Panbio Dengue Early ELISA (cat. no. E-DEN01P, lot.
no. 08140; Panbio, Brisbane, Queensland, Australia) was
used to detect NS-1 antigen in the acute plasma specimens
only, following the manufacturer’s instructions. A positive
specimen was deﬁned as having >11 Panbio units; <9
Panbio units was deﬁned as negative; and 9–11 Panbio
units was equivocal and the specimen retested to conﬁrm
the result.
Panbio units were calculated by ﬁrst determining the
assay cut-off value: the lot speciﬁc calibration factor was
multiplied by the average absorbance result of the kit cal-
ibrator (internal control, run in triplicate). Subsequently,
an index value was calculated for each patient specimen
by dividing the specimen absorbance result by the cut-
off value. Finally the Panbio units were determined by
multiplying the index value by 10.
2.5. Dengue IgM and IgG antibody capture ELISAs
We used the dengue IgM (Panbio: cat. no. E-DEN01M,
lot. no. 08316) and IgG (Panbio: cat. no. E-DEN02G, lot.
no. 09080) antibody capture ELISAs to detect IgM and
IgG antibodies in both the acute and convalescent plasma
specimens, following the manufacturer’s instructions. A
positive specimen was deﬁned as having >11 Panbio units
for IgM and >22 for IgG antibodies; <9 and <18 Panbio
34 W. Watthanaworawit et al. / Transactions of the Royal Society
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units was deﬁned as negative for IgM and IgG antibodies,
respectively; 9–11 Panbio units was equivocal for IgM and
18–22 Panbio units was equivocal for IgG antibodies and
the specimen retested to conﬁrm the result. Panbio units
were calculated as described above.
2.6. Classiﬁcation of dengue infection status
Dengue infection was classiﬁed using the above
described commercial serological assays as ‘conﬁrmed’
acute dengue infection based on WHO dengue diagnos-
tic criteria as deﬁned in Table 1. ‘Conﬁrmed’ acute dengue
cases were those that demonstrated an IgM or IgG anti-
body sero-conversion based on paired serum collections.16
Patients with static IgM positivity (i.e., positive in both
acute and convalescent specimens, but with no rise in
Panbio units) were considered to have evidence of recent
dengue infection.
2.7. Data Analysis
All statistical analyses were performed by using
STATA/SE for Macintosh, version 10.1 (Stata Corporation,
College Station, TX, USA). Continuous variables were com-
pared using Wilcoxon rank sum test (since non-normally
distributed). Characteristics of the tests were analysed in
2 x 2 tables using the ‘diagt’ routine.20 The McNemar test
was used to compare sensitivities of the tests.
3. Results
3.1. Patients
Two hundred and twenty nine patients were examined.
All patients met the WHO clinical case deﬁnition for acute
dengue infection.21 One hundred and sixty two patients
(71%) returned for the follow-up specimen collection visit
and were considered further.
Of the 162 patients included in the current analysis, 72
patients (44%) were given a laboratory conﬁrmed diagno-
sis of dengue infection by paired serology (Table 1). Four
patients were found to have evidence of recent dengue
infection. The demographic and clinical data of the patients
are shown inTable2. Patientswithconﬁrmeddengue infec-
tion had lower white cell counts (4.8 vs 7.2, P<0.0001)
and platelets (147 vs. 162, P=0.03) than patients with non-
dengue infection.
Twenty six patients (16%) were found to have non-
dengue causes for their illness: four patients (2%) grew
Salmonella typhi from blood cultures, by serology nine
patients (6%) had murine typhus, seven (4%) had scrub
typhus, and six (4%) had leptospirosis. Only one patient
had evidence of dual infection: acute secondary dengue
and typhoid; this patient had positive NS-1 antigen and
dengue rRT-PCR and also grew Salmonella typhi from a
blood culture.
The serotype of dengue virus was sought by performing
nested RT-PCR on the acute specimens from the 72 sero-
logically conﬁrmed cases. Seventy one of the cases (99%)
were serotype 3, with the remaining case serotype 2. The
four patients with serological evidence of recent dengue
infection were negative in the nested RT-PCR.
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Table 2
Demographic and clinical data of patients (n=162)
Dengue cases (n=72) Non-dengue cases (n=90)
Sex (male) 42/72 (58%) 56/90 (62%)
Age (years) 23 (range: 15–63) 27 (range: 15–60)
Headache 72/72 (100%) 86/90 (96%)
Arthralgia 55/72 (76%) 67/90 (74%)
Myalgia 44/72 (61%) 57/90 (63%)
Retro-orbital pain 46/72 (64%) 52/90 (58%)
Rash 4/72 (6%) 4/90 (4%)
Fever duration (days) 2 (range: 1–5) 2 (range: 1–6)
3–39.2)
0–14.6)
6.4)
–196)Presenting temperature (◦C) 38.8 (IQR: 38.
Haemoglobin (g/dL) 13.3 (IQR: 12.
White cell count (x103/mm3) 4.8 (IQR: 3.6–
Platelets (x103/mm3) 147 (IQR: 106
3.2. Comparison of the characteristics of the individual
diagnostic tests
The performance characteristics of NS-1 antigen detec-
tion, rRT-PCR, and IgM antibody detection in the acute
plasma specimen against our ‘gold standard’ of paired
serologyare shown inTable3.NS-1antigenor IgMantibody
test alone had low sensitivity compared with the paired
serology result, 54%and17% respectively. rRT-PCRsensitiv-
itywas89%, signiﬁcantlyhigher thanbothNS-1antigenand
IgM antibody tests (P<0.00001). Speciﬁcities of NS-1 anti-
gen detection, rRT-PCR, and IgM antibody detection were
100%, 96% and 88% respectively.
The effect of fever duration at presentation on assay
sensitivity is shown in Figure 1. NS-1 antigen sensitivity
peaked in the early stages of fever (three days of fever at
presentation). IgM antibody sensitivity rose later, peaking
in patients presenting with ﬁve days of fever. The sensi-
tivity of rRT-PCR remained high throughout. However, as a
result of the relatively small number of specimens on each
day, particularly for four and ﬁve days of fever, the 95%
conﬁdence intervals around the sensitivities are wide.3.3. Comparison of the characteristics of diagnostic test
combinations
The performance characteristics of combinations of the
acute specimen tests are shown in Table 3 (combined by
Table 3
Diagnostic accuracy of NS-1 antigen detection, rRT-PCR, and IgM antibody detect
Tests Paired serology result Sensitivi
Dengue Not dengue
Individual assays NS-1 + 39 0 54.2 (42.
− 33 90
rRT-PCR + 64 4 88.9 (79.
− 8 86
IgM + 12 11 16.7 (8.9
− 60 79
Combined assays NS-1+rRT-PCR + 67 4 93.1 (84.
− 5 86
NS-1+IgM + 43 11 59.7 (47.
− 29 79
rRT-PCR+IgM + 66 15 91.7 (82.
− 6 75
NS-1+rRT-PCR+IgM + 67 15 93.1 (84.
− 5 75
rRT: reverse transcriptase real-time; PPV: positive predictive value; NPV: negativ38.4 (IQR: 38.0–38.9)
13.7 (IQR: 12.1–14.4)
7.2 (IQR: 5.2–9.7)
162 (IQR: 133–212)
an ‘OR’ operator). The overall sensitivity of rRT-PCR com-
bined with IgM antibody detection (92%) was signiﬁcantly
better than IgM antibody detection alone (P<0.00001), but
not signiﬁcantly better than rRT-PCR alone (P=0.5). This
was also true for the combination of IgM+NS-1+rRT-PCR
(93%), which was signiﬁcantly better than NS-1 antigen or
IgM antibody detection alone (P<0.00001), but not better
than rRT-PCR alone (P=0.2). The combination of NS-1+rRT-
PCR was signiﬁcantly more sensitive than NS-1 antigen
detection alone (P<0.00001), but was not signiﬁcantly bet-
ter than rRT-PCR alone (P=0.2). NS-1+IgM was signiﬁcantly
more sensitive than IgM antibody alone (P<0.0001), but
not signiﬁcantly better than NS-1 antigen detection alone
(P=0.1). Combining tests resulted in a fall in speciﬁcity.
Combining rRT-PCR with IgM antibody alone or with IgM
antibody and NS-1 antigen resulted in a speciﬁcity of 83%,
whereas combining NS-1 antigen with rRT-PCR or IgM
antibody, the speciﬁcities were 96% and 88% respectively.
4. Discussion
An accurate and rapid method for the diagnosis of
dengue virus infection would facilitate optimal patient
management. In resource-poor settings, diagnosis based
on clinical features is the norm but, as shown in the
current study, clinical diagnosis of dengue using WHO
criteria is non-speciﬁc: only 72/162 (44%) of patientsmeet-
ing the clinical case deﬁnition in the current study had
ion on acute plasma specimens
ty % (95% CI) Speciﬁcity % (95% CI) PPV % (95% CI) NPV % (95% CI)
0-66.0) 100 (96.0-100) 100 (91.0-100) 73.2 (64.4-80.8)
3-95.1) 95.6 (89.0-98.8) 94.1 (85.6-98.4) 91.5 (83.9-96.3)
-27.3) 87.8 (79.2-93.7) 52.2 (30.6-73.2) 56.8 (48.2-65.2)
5-97.7) 95.6 (89.0-98.8) 94.4 (86.2-98.4) 94.5 (87.6-98.2)
5-71.1) 87.8 (79.2-93.7) 79.6 (66.5-89.4) 73.1 (63.8-81.2)
7-96.9) 83.3 (74.0-90.4) 81.5 (71.3-89.2) 92.6 (84.6-97.2)
5-97.7) 83.3 (74.0-90.4) 81.7 (71.6-89.4) 93.8 (86.0-97.9)
e predictive value.
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aboratory conﬁrmeddengue infection. Twenty sixpatients
16%) meeting the dengue clinical case deﬁnition had an
lternative, and antibiotic-treatable, cause for their ill-
ess. Unfortunately, for a deﬁnitive laboratory diagnosis
f dengue using current techniques often a combination of
ests are required.22 In spite of this, many clinical labora-
ories continue to rely on a single assay to conﬁrm dengue
nfection, which, as we have demonstrated, may lead to
iagnostic inaccuracy. Additionally, many currently avail-
ble rapid immunochromatographic tests (ICT), used in the
eld for clinical decision-making, suffer from poor perfor-
ance characteristics.19
Antigen or molecular-based assays are attractive
ptions for rapid diagnosis of dengue infection because
hey can potentially detect infection before an antibody
esponse develops. Indeed, detection of dengue NS-1 anti-
en by ELISA allowed detection of infection prior to
ero-conversion and could be detected in serum from the
rst day after onset of fever up to day nine of fever.23 Shu
t al. conﬁrmed the ability of PCR to detect dengue virus
NA between day one and day seven of fever.11
In the current study, NS-1 antigen and acute IgM anti-
ody detection did not detect the majority of conﬁrmed
engue cases. The positive predictive value (PPV) for NS-
antigen detection was excellent (100%) but the negative
redictive value (NPV) was poor at 73%, resulting in many
atients with conﬁrmed dengue being missed if the test
ere to be used alone. Acute IgM antibody detection had
oor PPV and NPV (52% and 57% respectively), resulting in
any misdiagnosed cases. rRT-PCR had the best operating
haracteristics (sensitivity 89%, speciﬁcity 96%, PPV 94%,
PV 92%) and would be potentially sufﬁcient as a single
ssay for conﬁrmation of dengue infection, since it allows
or accurate conﬁrmation or refuting of infection. The com-
inations of NS-1+rRT-PCR or NS-1+IgM+rRT-PCR resulted
n the highest sensitivity (93%), although this was asso-
iated with an inevitable fall in speciﬁcity (96% and 83%
espectively).
Compared to previous studies onNS-1 antigen ELISAwe
eport a slightly lower sensitivity. Dussart et al. found the
anbioNS-1antigenELISA tohave a sensitivity of 60%when
sedonstoredserumspecimens fromFrenchGuiana14 and,) rRT-PCR, (B) NS-1 antigen and (C) IgM antibody.
in a similar study from Puerto Rico, Bessoff et al. reported a
sensitivity of 65%.13 On prospectively collected specimens
from clinically suspected dengue cases in Laos, Blacksell et
al. reporteda sensitivityof 63%.24 The sensitivityof rRT-PCR
was slightly better than reported by the original authors
who found that PCR detected viral RNA 83% of acute spec-
imens from patients with conﬁrmed dengue.11 Comparing
operating characteristics of assays between studies can be
difﬁcult, since there are many potential confounding fac-
tors. Firstly, in the current study, specimens were collected
prospectively on patients with illness broadly compatible
with dengue whereas several of the previous evaluations
of NS-1 antigen ELISA have been retrospective, using well
characterised serum specimen collections. We feel that the
results presented here are likely to more accurately reﬂect
the operating characteristics of the tests in a routine clin-
ical setting. Secondly, infections due to dengue serotype 3
predominated in our study, and previous work has noted
that the Panbio NS-1 antigen ELISA may miss infections
caused by this serotype.24 Thirdly, timing of presentation
and specimen collection may affect assay performance: in
our study, most patients presented very early in the course
of their infection. Although we demonstrated trends in the
sensitivity of each assay, the small number of patients pre-
senting with more than three days of fever limited our
ability to perform statistical analysis. Previous studies have
demonstrated the effect of timing of presentation on NS-1
antigen and IgM antibody24 or PCR11 assays, but no com-
parison between antigen detection, PCR, and serology on
the same patient population has been described. Finally,
infection status (primary infection versus secondary infec-
tion) may also make study-to-study comparisons difﬁcult.
We identiﬁed very few patients with acute primary infec-
tion (3/72, usingPanbiokit criteria), resulting in an inability
to determine potential differences in test characteristics
between primary and secondary infections. We plan to
perform further work to delineate the optimum sampling
‘window’ for each assay for patients with primary and sec-
ondary dengue infection.
This work suggests that, in a clinical setting, combined
tests (IgM antibody ELISA, NS-1 antigen ELISA and/or rRT-
PCR) are still required to conﬁdentlydiagnose acutedengue
l Society
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infection from a single blood specimen: at least a com-
bination of two tests, either agent detection (rRT-PCR) or
antigen detection (NS-1) plus IgMantibody should be used.
Unfortunately, this results in slow laboratory conﬁrma-
tion of dengue infection. Given that rRT-PCR was the most
accurate single assay in our assessment, prospective evalu-
ations of new ﬁeld-deployable rapid diagnostic molecular
tests, for example LAMP-based assays, are planned. These
evaluations will include comparisons with the newer com-
bined NS-1 antigen and IgM antibody ICT rapid test kits.
Although cheap and/or ﬁeld-deployable PCR systems are
somewayoff at the current time, progresshasbeenmade in
this area and development and reﬁnement of current tech-
niques may result in nucleic acid detection becoming the
standard for rapid dengue diagnosis even in resource-poor
settings.25
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